Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

University gearing up for Varsity Hockey Series
2013-05-09

09 May 2013

Our university will play host to the University of Pretoria (Tukkies), the Northwest University (Pukke) and the University of the Witwatersrand in the Varsity Hockey series. 

All matches will take place from Saturday to Monday at 14:30 and 16:00. 

The programme is as follow:

Saturday 11 May 2013

14:30 – NWU PUKKE vs Wits
16:00 – UP Tukkies vs UFS Kovsies

Sunday 12 May 2013

14:30 – NWU PUKKE vs UFS Kovsies
16:00 – Wits vs UP Tukkies

Monday 13 May 2013

14:30 – NWU PUKKE vs UP Tukkies
16:00 – UFS Kovsies vs Wits

The NWU PUKKE is currently the front runner with 14 points already on the log. PUKKE should also be the toughest team to beat this weekend, with the inclusion of two Protea players in their side. Sulette Damons and Celia Evans will be part of the Northwest’s attempts to stay at the top.

Kovsies and UP Tukkies will also boast with Proteas. Izelle Lategan and Tanya Brits will strengthen Kovsies’ team, while Lilian du Plessis is part of the Tukkies team. Both our university and Tukkies have 10 points after the first three matches played in Potchefstroom.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept